Last reviewed · How we verify
Fucidin® cream — Competitive Intelligence Brief
marketed
Steroid antibiotic
Bacterial elongation factor G (EF-G)
Dermatology / Infectious Disease
Small molecule
Live · refreshed every 30 min
Target snapshot
Fucidin® cream (Fucidin® cream) — LEO Pharma. Fusidic acid inhibits bacterial protein synthesis by binding to elongation factor G, preventing bacterial growth.
Comparator set (1 drugs)
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Fucidin® cream TARGET | Fucidin® cream | LEO Pharma | marketed | Steroid antibiotic | Bacterial elongation factor G (EF-G) | |
| Fusidic Acid 1% | Fusidic Acid 1% | Baxis Pharmaceuticals, Inc. | phase 3 | Steroid antibiotic | Bacterial elongation factor G (EF-G) |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Steroid antibiotic class)
- Baxis Pharmaceuticals, Inc. · 1 drug in this class
- LEO Pharma · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Fucidin® cream CI watch — RSS
- Fucidin® cream CI watch — Atom
- Fucidin® cream CI watch — JSON
- Fucidin® cream alone — RSS
- Whole Steroid antibiotic class — RSS
Cite this brief
Drug Landscape (2026). Fucidin® cream — Competitive Intelligence Brief. https://druglandscape.com/ci/fucidin-cream. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing